BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22495125)

  • 1. Salivary duct carcinoma: what is already known, and can we improve survival?
    Wee DT; Thomas AA; Bradley PJ
    J Laryngol Otol; 2012 Jul; 126 Suppl 2():S2-7. PubMed ID: 22495125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland.
    Yamamoto H; Uryu H; Segawa Y; Tsuneyoshi M
    Pathol Int; 2008 May; 58(5):322-6. PubMed ID: 18429833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Salivary duct carcinoma of the sublingual gland--a case report].
    Sartorius C; Gille F; Bédrossian-Pfingsten J; Kempf HG
    Laryngorhinootologie; 2006 Jul; 85(7):517-9. PubMed ID: 16586279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.
    Jaehne M; Roeser K; Jaekel T; Schepers JD; Albert N; Löning T
    Cancer; 2005 Jun; 103(12):2526-33. PubMed ID: 15900577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy.
    Nabili V; Tan JW; Bhuta S; Sercarz JA; Head CS
    Head Neck; 2007 Oct; 29(10):907-12. PubMed ID: 17563907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
    Monteiro LS; Bento MJ; Palmeira C; Lopes C
    J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and outcome analysis of salivary duct carcinoma.
    Han MW; Roh JL; Choi SH; Nam SY; Lee HJ; Cho KJ; Lee SW; Kim SY
    Auris Nasus Larynx; 2015 Dec; 42(6):472-7. PubMed ID: 26028371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
    Williams MD; Roberts D; Blumenschein GR; Temam S; Kies MS; Rosenthal DI; Weber RS; El-Naggar AK
    Am J Surg Pathol; 2007 Nov; 31(11):1645-52. PubMed ID: 18059220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary duct carcinoma metastatic to inguinal lymph node: a case report of salivary duct carcinoma with distant metastasis diagnosed by fine-needle aspiration.
    Bhalla R; Parker DC; Tadros TS
    Diagn Cytopathol; 2006 Jan; 34(1):41-4. PubMed ID: 16355374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological therapy of salivary duct carcinoma.
    Nashed M; Casasola RJ
    J Laryngol Otol; 2009 Feb; 123(2):250-2. PubMed ID: 18405406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic analysis of adenoid cystic carcinoma of major salivary glands of 64 cases].
    Qing J; Zhang Q; Wei MW; Guo ZM
    Ai Zheng; 2006 Sep; 25(9):1138-43. PubMed ID: 16965658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary duct carcinoma.
    Hosal AS; Fan C; Barnes L; Myers EN
    Otolaryngol Head Neck Surg; 2003 Dec; 129(6):720-5. PubMed ID: 14663441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.
    Al-Qahtani KH; Tunio MA; Bayoumi Y; Gurusamy VM; Bahamdain FA; Fatani H
    J Otolaryngol Head Neck Surg; 2016 May; 45(1):32. PubMed ID: 27184361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study.
    Anacak Y; Miller RC; Constantinou N; Mamusa AM; Epelbaum R; Li Y; Calduch AL; Kowalczyk A; Weber DC; Kadish SP; Bese N; Poortmans P; Kamer S; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):315-20. PubMed ID: 21075560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Salivary duct carcinoma--a clinicopathological analysis of five cases].
    Bień S; Sygut J; Kopczyński J; Postuła S; Ziółkowska M
    Otolaryngol Pol; 2007; 61(1):33-8. PubMed ID: 17605416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and survival rates for parotid duct carcinoma patients.
    Shi S; Fang Q; Liu F; Zhong M; Sun C
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1929-31. PubMed ID: 25209384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The number and ratio of positive lymph nodes are independent prognostic factors for patients with major salivary gland cancer: Results from the surveillance, epidemiology, and End Results dataset.
    Qian K; Sun W; Guo K; Zheng X; Sun T; Chen L; Xiang J; Li D; Wu Y; Ji Q; Wang Z
    Eur J Surg Oncol; 2019 Jun; 45(6):1025-1032. PubMed ID: 30472214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland.
    Chen AM; Garcia J; Bucci MK; Quivey JM; Eisele DW
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):138-43. PubMed ID: 17049183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [About the prognostic value of Her-2 gene-amplification and cell-proliferation in salivary duct carcinoma of the major salivary glands - a pilot-study].
    Jaehne M; Jäkel KT; Röser K; Ussmüller J; Löning T
    Laryngorhinootologie; 2001 Sep; 80(9):525-9. PubMed ID: 11555785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.